Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia

The Journal of Infectious Diseases
Zacharie TaoufiqDominique Mazier

Abstract

Acute clinical manifestations of falciparum malaria, such as multiorgan failure and cerebral malaria, occur unpredictably and lead to coma and death within hours if left untreated. Despite the emergency administration of effective antimalarial drugs, 15%-20% of patients die. Other therapeutic approaches are therefore urgently needed. There is increasing evidence that endothelial changes play a key role in the pathogenesis of severe malaria. We therefore used coculture models to study interactions between infected erythrocytes and endothelium. We found that adhesion of Plasmodium falciparum to endothelial cells in vitro activated the Rho kinase signaling pathway, which is strongly involved in various vascular diseases. When added concomitantly with parasites, the Rho kinase inhibitor fasudil (HA-1077), a drug already in clinical use, decreased both NF-kappaB activation and endothelial cell apoptosis. Fasudil also helped to restore endothelial barrier integrity after P. falciparum adhesion. Rho kinase inhibition thus appears to be a promising adjunctive therapeutic approach to the management of severe human malaria.

References

Aug 20, 1976·Science·W Trager, J B Jensen
Aug 1, 1990·The American Journal of Tropical Medicine and Hygiene·J D Chulay, C F Ockenhouse
Nov 1, 1995·The American Journal of Tropical Medicine and Hygiene·S NakazawaM Aikawa
Apr 1, 1994·Annals of Tropical Medicine and Parasitology·I D GoodyerD J Hayes
Jul 11, 1996·The New England Journal of Medicine·M B van HensbroekD Kwiatkowski
Jul 1, 1996·The Journal of Clinical Investigation·J Loscalzo
Jun 11, 1999·The American Journal of Physiology·M Ho, N J White
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S Etienne-MannevilleP O Couraud
Feb 28, 2002·Journal of Cardiovascular Pharmacology·Hiroaki Shimokawa
Sep 12, 2003·Trends in Immunology·Nicholas H Hunt, Georges E Grau
Oct 25, 2003·Journal of Cell Science·Svetlana M StamatovicAnuska V Andjelkovic
Nov 25, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Jerome W Breslin, Sarah Y Yuan
Mar 23, 2004·Annals of the New York Academy of Sciences·Paco PinoDominique Mazier
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Valéry CombesMalcolm E Molyneux
Aug 21, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Sebastian WolfrumJames K Liao
Sep 17, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·R ChillemiS Musumeci
Dec 18, 2004·Drug News & Perspectives·Yoshitaka HirookaAkira Takeshita
Jan 6, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Yoshitaka Hirooka, Hiroaki Shimokawa
Feb 12, 2005·American Journal of Physiology. Heart and Circulatory Physiology·M Carmen MartínezRamaroson Andriantsitohaina
Feb 26, 2005·Infection and Immunity·Christoph Josef HemmerEmil Christian Reisinger
May 3, 2005·Nature Reviews. Drug Discovery·Bernhard K MuellerNicole Teusch
Jul 12, 2005·Journal of the Neurological Sciences·Masato ShibuyaUNKNOWN Fasudil Ischemic Stroke Study Group
Jul 20, 2005·Molecular and Biochemical Parasitology·Francesco SilvestriniPietro Alano
Aug 27, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Tetsuya NakakukiTakeshi Nakano
Aug 30, 2005·Lancet·Arjen DondorpUNKNOWN South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group
Sep 28, 2005·Current Neurovascular Research·Nicolas ColtelGeorges E Grau
Oct 4, 2005·The Journal of Prosthetic Dentistry·Saadet Saglam AtsuCemal Atakan
Nov 16, 2005·Journal of the American College of Cardiology·Ralph M VicariUNKNOWN Fasudil Study Group
Nov 22, 2005·Lancet Neurology·Richard IdroCharles R J C Newton
Apr 1, 2006·Circulation Research·Eva Cernuda-Morollón, Anne J Ridley
Apr 18, 2006·International Journal for Parasitology·Isabelle M Medana, Gareth D H Turner
Aug 26, 2006·Molecular and Biochemical Parasitology·Zacharie TaoufiqIoannis Vouldoukis
Sep 22, 2006·Antioxidants & Redox Signaling·Cristen PantanoYvonne M W Janssen-Heininger
Mar 3, 2007·The Journal of Infectious Diseases·Isabelle M Medana, Gareth D H Turner

❮ Previous
Next ❯

Citations

Apr 20, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Silvia S Kang, Dorian B McGavern
Feb 8, 2013·Nature Medicine·Louis H MillerThomas E Wellems
Mar 23, 2011·Current Opinion in Hematology·Hani KimKevin C Kain
Mar 2, 2011·Malaria Journal·Zacharie TaoufiqDominique Mazier
Nov 19, 2010·Parasites & Vectors·Anne-Lise BienvenuStephane Picot
Apr 6, 2012·PloS One·Mingli LiuJonathan K Stiles
Mar 6, 2013·PLoS Pathogens·Christina M TaylorMakedonka Mitreva
Mar 6, 2012·Revue neurologique·F GayA Moreno
Mar 1, 2011·Microvascular Research·Caroline C McGownZoë L S Brookes
Jan 23, 2010·Experimental Parasitology·Judith H Waknine-GrinbergJacob Golenser
Oct 14, 2008·Trends in Parasitology·Danny A MilnerStephen J Rogerson
Aug 2, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Na WangLi Chu
Jan 21, 2012·The American Journal of Pathology·Mark R GillrieMay Ho
May 29, 2012·Anais Da Academia Brasileira De Ciências·Laura N CruzCélia R S Garcia
Aug 5, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Sergine ZougbédéAlicia Moreno
Apr 30, 2017·Tissue Barriers·Mark R Gillrie, May Ho
May 11, 2018·The Korean Journal of Parasitology·Maha M A BasyoniDalia Ibrahim Ismail
Apr 14, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Min QiuJunzhi Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.